VCM
JAZZ icon

Versant Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Versant Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Buy
2,357
+305
+15% +$66.8K 0.05% 247
2026
Q1 		$388K Sell
2,052
-106
-5% -$18.5K 0.04% 346
2025
Q4 		$367K Buy
2,158
+1,028
+91% +$158K 0.05% 297
2025
Q3 		$149K Sell
1,130
-7
-0.6% -$840 0.02% 574
2025
Q2 		$121K Buy
1,137
+79
+7% +$8.58K 0.02% 610
2025
Q1 		$131K Buy
1,058
+91
+9% +$11.9K 0.02% 542
2024
Q4 		$119K Buy
967
+350
+57% +$41.3K 0.03% 263
2024
Q3 		$68.7K Buy
617
+346
+128% +$37.9K 0.02% 344
2024
Q2 		$28.9K Buy
271
+269
+13,450% +$29.6K 0.01% 580
2024
Q1 		$241 Hold
2
– – ﹤0.01% 1815
2023
Q4 		$246 Sell
2
-3
-60% -$374 ﹤0.01% 1843
2023
Q3 		$647 Hold
5
– – ﹤0.01% 1648
2023
Q2 		$620 Buy
5
+3
+150% +$404 ﹤0.01% 1766
2023
Q1 		$290 Hold
2
– – ﹤0.01% 1665
2022
Q4 		$319 Hold
2
– – ﹤0.01% 1515
2022
Q3 		$0 Buy
+2
New +$304 ﹤0.01% 1532
2020
Q2 		– Sell
-3
Closed – – 1423
2020
Q1 		$0 Buy
+3
New +$388 ﹤0.01% 1487

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Versant Capital Management's JAZZ Position: Q2 2026 in Review

Versant Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 15% in Q2 2026, buying an estimated $66.8K and bringing the position to 2,357 shares worth $568K. The position accounts for 0.05% of the portfolio, ranked #247.

Versant Capital Management first reported a position in JAZZ in Q1 2020 and has held it in 17 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Versant Capital Management held 2,357 shares of Jazz Pharmaceuticals worth $568K as of Q2 2026.
  • Versant Capital Management bought 305 Jazz Pharmaceuticals shares in Q2 2026, an estimated $66.8K.
  • Jazz Pharmaceuticals made up 0.05% of Versant Capital Management's portfolio in Q2 2026, its #247 holding.
  • Versant Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 17 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.